ResMed Inc. (RMD)
NYSE: RMD · Real-Time Price · USD
237.27
+5.69 (2.46%)
At close: Dec 20, 2024, 4:00 PM
233.23
-4.04 (-1.70%)
After-hours: Dec 20, 2024, 7:00 PM EST
ResMed Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for ResMed stock have an average target of 230.11, with a low estimate of 180 and a high estimate of 283. The average target predicts a decrease of -3.02% from the current stock price of 237.27.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for ResMed stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Hold | 5 | 5 | 5 | 5 | 5 | 6 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Hold Initiates $250 | Hold | Initiates | $250 | +5.37% | Dec 13, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $224 → $232 | Hold | Maintains | $224 → $232 | -2.22% | Oct 25, 2024 |
| Keybanc | Keybanc | Buy Maintains $251 → $266 | Buy | Maintains | $251 → $266 | +12.11% | Oct 25, 2024 |
| Baird | Baird | Buy Maintains $280 → $283 | Buy | Maintains | $280 → $283 | +19.27% | Oct 25, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Oct 25, 2024 |
Financial Forecast
Revenue This Year
5.16B
from 4.69B
Increased by 10.22%
Revenue Next Year
5.53B
from 5.16B
Increased by 7.16%
EPS This Year
9.46
from 6.92
Increased by 36.68%
EPS Next Year
10.40
from 9.46
Increased by 9.96%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 5.5B | 5.9B | 6.4B | ||
| Avg | 5.2B | 5.5B | 5.9B | ||
| Low | 5.0B | 5.3B | 5.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 17.0% | 15.0% | 15.6% | ||
| Avg | 10.2% | 7.2% | 7.0% | ||
| Low | 5.9% | 2.5% | 1.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 10.26 | 11.59 | 12.75 | ||
| Avg | 9.46 | 10.40 | 11.33 | ||
| Low | 8.97 | 9.79 | 10.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 48.2% | 22.6% | 22.6% | ||
| Avg | 36.7% | 10.0% | 9.0% | ||
| Low | 29.6% | 3.5% | -0.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.